
Enzyme (MLN) price today
Live MLN chart
Enzyme (MLN) price details

Enzyme price history
Enzyme technical analysis
Enzyme (MLN) sentiment
About Enzyme
What Is Enzyme
Enzyme is the native token of the Enzyme Finance protocol, a decentralized platform for on-chain asset management in the DeFi space. Originally launched as Melon Protocol in 2017 by founders Mona El Isa and Reto Trinkler, it rebranded to Enzyme in 2021 to better reflect its focus on enzymatic efficiency in finance. The core concept revolves around democratizing asset management. Users can create customized funds, called "vaults," that others invest in, all powered by blockchain transparency. The ecosystem includes tools for fund managers to handle portfolios with automated strategies, integrations with various DeFi protocols, and governance features where MLN holders vote on updates. Backed by a team with finance and tech expertise, Enzyme aims to bridge traditional investing with crypto, fostering a community-driven approach to wealth management.Origin and Background
Enzyme emerged from the vision of making hedge fund-like structures accessible via blockchain, starting in Zurich, Switzerland.Founding Team
Led by Mona El Isa, a former Goldman Sachs trader, and Reto Trinkler, a blockchain developer.Core Concept
It emphasizes composable, permissionless fund management with low barriers to entry.How Does Enzyme Work
Enzyme operates on the Ethereum blockchain, leveraging smart contracts to automate asset management tasks. Users deploy vaults as smart contracts, which can hold various ERC-20 tokens and execute strategies like yield farming or trading. The protocol uses a proof-of-stake-like mechanism for governance, but it's not a consensus algorithm for the chain itself—it's built on Ethereum's security. Private keys secure user wallets, while public keys enable transparent transactions. Technical principles include modular plugins for strategies, risk management tools, and performance fees that reward managers. This setup ensures decentralized control, with MLN tokens used for paying fees and participating in governance votes.Blockchain and Consensus
Relies on Ethereum's proof-of-stake for underlying security.Smart Contracts
Core to vaults, enabling automated, trustless fund operations.Technical Principles
Employs public-private key cryptography for secure, verifiable interactions.How Is New Enzyme Created
Enzyme (MLN) has a fixed total supply of 2,664,826 tokens, with no new issuance through mining. It was initially distributed via a token sale and community rewards. There's no ongoing inflation; the supply is capped to maintain scarcity. Rewards come from protocol fees, where a portion goes to MLN stakers or governance participants. Users can earn through providing liquidity or managing successful vaults, but new tokens aren't minted—circulation increases via unlocks from vesting schedules.Issuance Method
Pre-mined and distributed initially, with no further creation.Mining/Staking Mechanisms
Staking MLN for governance influence, not for block production.Total Supply Limit
Fixed at around 2.66 million tokens.The Use Cases of Enzyme
Enzyme shines in DeFi by allowing users to build and invest in diversified crypto portfolios without intermediaries. It's ideal for creating thematic funds, like those focused on NFTs or yield optimization. Governance lets MLN holders propose and vote on protocol changes. Cross-border transfers are seamless via integrated DeFi tools. It supports smart contract-based strategies for automated trading and risk hedging, making it a hub for professional-grade asset management in crypto.DeFi Applications
Fund creation, investing, and yield strategies.Governance
Token holders influence decisions.Other Scenarios
NFT integrations and cross-protocol composability.Buy, Send, or Store Enzyme
To buy Enzyme (MLN), use exchanges like WEEX, which offers secure trading pairs. Register on WEEX to earn a free 20 USDT bonus, making it a trusted spot to start trading crypto assets like Enzyme. https://www.weex.com/how-to-buy For storage, opt for hot wallets like MetaMask for quick access or cold wallets like Ledger for enhanced security. Sending involves entering the recipient's address in your wallet app—always double-check to avoid errors. Secure your private keys and enable two-factor authentication.Purchasing Channels
WEEX Exchange or OTC platforms.Wallet Types
Hot for convenience, cold for safety.Storage Security
Use hardware wallets and backup seeds.Pros & Cons / Risks
- **Pros**: High decentralization empowers users; strong security via Ethereum; fast setup for funds; community governance reduces central control. - **Cons/Risks**: Price volatility can lead to losses; regulatory changes might impact DeFi; smart contract bugs pose technical risks; market uncertainty affects adoption.Comparison (optional)
Compared to Ethereum's ETH, Enzyme's MLN focuses on asset management rather than being a general-purpose token. While ETH powers the network, MLN enables specialized DeFi funds, positioning it as a niche player versus ETH's broad utility.Conclusion / Next Steps
Enzyme holds potential for growth in DeFi as more users seek managed crypto investments. Future directions include expanded integrations and scalability upgrades. Check the whitepaper or roadmap for details. Join the community to stay updated—sign up on WEEX to explore trading options.Market & Ecosystem
As of 2025-09-11, Enzyme continues to evolve in the DeFi landscape.Market Cap & Trading Volume
Market cap stands at approximately $100 million, with 24-hour trading volume around $5 million.Exchanges Where It’s Listed
Available on WEEX and other major platforms.Community Size & Activity
Active on Twitter (50k followers), Reddit (20k members), and Telegram (15k users) with regular discussions.Ecosystem Growth
Partnerships with DeFi protocols and growing developer activity through grants.Official links
Social media and community
FAQ
1. What is the current price of Enzyme (MLN) in USD?
2. What is the market capitalization of Enzyme (MLN)?
3. What is the circulating supply of Enzyme (MLN)?
4. What factors influence the price of Enzyme (MLN)?
5. Is Enzyme (MLN) a good investment?
6. Where can I buy Enzyme (MLN)?
7. What are the typical fees when buying Enzyme (MLN)?
8. What are some technical indicators used for analyzing Enzyme (MLN)?
Currency price converter
Popular
Global prices
¥
₽
€
$
¥
NT$
₫
aed
₴
zł
R$
Rp
$
₼
฿
RsHow to buy
Enzyme news
Argentine Bitcoiners Debut “The Genesis Of Satoshi Nakamoto” Artwork In Downtown Buenos Aires
Bitcoin.ar presented the 2.4-meter stainless steel and glass cube “The Genesis of Satoshi Nakamoto” on October 29 at Polo Dot as part of LABITCONF 2026’s Open Fest.
Broadcom (AVGO) : AI Growth, Fund Positioning, and Guarantee Risk
Broadcom (AVGO) recently fell with the semiconductor sector, closing down 10.43% at $291.53 on November 5. The shares rebounded more than 4% in premarket trading on November 6. Concerns that election results could lead to tighter AI rules and slower data center approvals contributed to a broad sell-off, with a semiconductor index falling about 12%. The move appears tied mainly to sector sentiment and policy concerns, with no clear company-specific negative catalyst identified.
Institutional trading and AI growth expectations are also in focus. ARK funds sold about $134 million of Broadcom shares over two sessions while adding to SpaceX. Citi maintained its Buy rating and projected that Broadcom’s AI semiconductor revenue could reach $115 billion in fiscal 2027, roughly doubling year over year. Broadcom had approximately $179.2 billion in signed contracts as of the prior quarter, while analysts estimated fourth-quarter AI chip revenue at about $21.7 billion. These forecasts will need to be tested against future results.
Contingent guarantees are another point for investors to monitor. Broadcom is providing guarantees tied to Anthropic’s AI rack-leasing arrangement, involving about $29 billion in the first phase and a second-phase plan of up to $43 billion. Banks plan to issue $21 billion in bonds to support related chip financing. The guarantee amounts are not the same as debt already incurred, but they add a potential risk to assess. Broadcom is scheduled to report its next quarterly results on December 9, when management’s outlook for fiscal 2027 AI demand will be closely watched. This article is for informational purposes only and is not investment advice.
Netflix (NFLX) Stock Rebounds: Insider Sales, Advertising, and Growth Plans
Several Netflix executives sold company shares in early November 2026. Co-CEO Theodore Sarandos sold 27,312 shares from November 3 to 4, valued at about $1.81 million. CFO Spencer Neumann sold shares worth approximately $612,000. Co-CEO Gregory Peters realized about $1.69 million, including transactions related to tax withholding. Chief Legal Officer David Hyman and director Bradford Smith also reduced their holdings. Executive sales can have different reasons and should not be viewed on their own as a measure of the company’s outlook.
After recent pressure, Netflix shares rebounded more than 4% around November 4. Bill Ackman’s Pershing Square Capital Management allocated about 5% of its portfolio to Netflix, while new AI features and positive views on the company’s technology prospects helped sentiment. Netflix reported third-quarter 2026 revenue of $13.44 billion and earnings per share of $0.87, both above expectations, though its forward outlook remains a key focus.
Advertising is one of Netflix’s main challenges. Delays to key ad product features led the company to reduce its annual advertising revenue outlook from $3 billion to $2.7 billion. Viewer engagement has also faced pressure from changes in content appeal and competition from platforms such as YouTube. Netflix is pursuing growth through live events, gaming, and advertising, with plans to expand its ad-supported offering to 15 markets while adjusting its workforce by about 6% to improve margins. Investors may want to monitor advertising growth, engagement, and profitability. This article is for informational purposes only and is not investment advice.
Carvana Earnings: Record Sales, Strong Profit, and Insider Share Sales
Carvana reported third-quarter net revenue of $8.04 billion, up 42.4% year over year and above the $7.7 billion market estimate. Retail units sold reached a record 217,385, an increase of 39.4%. Net income rose to $483 million, while adjusted EBITDA reached a record $800 million, reflecting gains in both revenue and profitability.
Management expects full-year 2026 adjusted EBITDA to reach the upper end of its $2.7 billion to $3.0 billion range. Needham maintained its Buy rating, named Carvana a top pick in transportation technology, and set a $100 price target. Strong results and guidance have drawn investor attention, though continued performance will depend on sales, margins, and operating costs.
Insider transactions are also on investors’ radar. A regulatory filing indicates that CFO Mark Jenkins planned to sell 63,800 shares on November 2, 2026, valued at approximately $4.35 million. Since August, he has planned sales totaling 191,300 shares. An executive share sale alone does not determine a company’s outlook; investors may also consider earnings, cash flow, and future guidance. This article is for informational purposes only and is not investment advice.
FCEL Stock: Data Center Opportunity, Manufacturing Costs, and Lawsuit Risk
FuelCell Energy (ticker: FCEL) provides fuel-cell power solutions. Growing electricity demand from AI data centers could create new business opportunities, while proposed pauses on new data center approvals in some areas have raised concerns about project timelines. A 75-megawatt power project may be affected, and FCEL shares recently fell as much as about 17% in a single session amid policy concerns.
FCEL signed an agreement with Fit Energy to provide up to 380 megawatts of fuel-cell power solutions. Its backlog is approximately $3.6 billion, with about 97% of its sales pipeline related to data centers. The company also drew the second installment under a $49 million financing arrangement backed by an export credit agency, supporting a green energy project and clean-energy exports. Recent leadership changes include Matthew Latino becoming CFO, digital infrastructure executive Peter Hopper joining the board, and John Dansby leading manufacturing scale-up. Converting orders into revenue will depend on production capacity, costs, and project execution.
FCEL reported third-quarter revenue of about $33 million, down approximately 29% year over year, and a net loss of roughly $45.3 million. Product costs and manufacturing overhead for the Fit Energy agreement exceeded the contract pricing, resulting in an approximately $17 million contract impairment charge. Securities class-action allegations concern disclosures about manufacturing capacity and costs; the case remains in the legal process. The deadline to seek appointment as lead plaintiff is November 10, 2026. FCEL’s growth opportunities come with execution, financing, and litigation risks. This article is for informational purposes only and is not investment advice.
Website
Whitepaper
GitHub
Reddit
X(Twitter)











